Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD

We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab for the rare disease of Mepolizumab or Placebo for Eosinophilic
Granulomatosis with Polyangiitis

This entry was posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology. Bookmark the permalink.

Leave a Reply

Your email address will not be published.